Editor(s):
(1) Dr. Koteshwara Mudigonda, Propharmex Company, India.
Reviewers:
(1) Col Mahendra Narain Mishra, Netaji Subhash Chandra Bose Subharti Medical College, India.
(2) Farkad Hawas Musa, University of Anbar, Iraq.
Additional Reviewers:
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 7.25/10
Average Peer review marks at publication stage: 8.5/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Col Mahendra Narain Mishra, India) | File 1 | File 2
Stage 2 | Peer review report_2 (Farkad Hawas Musa, Iraq) | File 1 | File 2
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA